Hoda Z Pourhassan

24PUBLICATIONS
28CO-AUTHORS
Haematological tumoursHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Psychological methodology, design and analysisTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 23, 2026
Clinical Implications of CD19-Negative Relapse Following CD19-Directed Therapy in B-Cell Acute Lymphoblastic Leukemia.

|Sep 10, 2025
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B-ALL With High Disease Burden.

Jose Tinajero, Kim Nguyen, Dat Ngo

|Sep 01, 2025
The efficacy of targeted and immune-based therapies in adults with TP53-mutated acute lymphoblastic leukaemia.

Hoda Pourhassan, Jose Tinajero, Huiyan Ma

|Jun 10, 2025
The integration of blinatumomab consolidation in the CALGB 10403 regimen for adults with B-cell precursor acute lymphoblastic leukaemia in measurable residual disease-negative remission.

Jose Tinajero, Dat Ngo, Maria Motta

|May 21, 2025
Comparison of CALGB 10403 and HyperCVAD in the treatment of Philadelphia chromosome negative acute lymphoblastic leukemia in adults ≥40 years old.

Purav Mehta, Dat Ngo, Jose Tinajero

|Apr 10, 2025
Hypomethylating agent and venetoclax are effective salvage therapies in relapsed/refractory early T-cell precursor acute lymphoblastic leukaemia.

Vaibhav Agrawal, Shukaib Arslan, Hoda Pourhassan

Pageof 4

Frequent Collaborators

13 joint publications

Ibrahim Aldoss

12 joint publications

Paul Koller

11 joint publications

Vaibhav Agrawal

9 joint publications

Monzr M Al Malki